Judy Chen
Advenchen Pharmaceuticals, LLC.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Judy Chen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:22 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07811297 · A Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM CancersAdvenchen Pharmaceuticals, LLC. · not yet recruiting · Endometrial Neoplasms, Ovarian Neoplasms, Soft Tissue Sarcoma (STS) · study director
- Ph1/Ph2NCT07811232 · A Study of AL58805 in Advanced, Metastatic GYN, STS or Breast CancersAdvenchen Pharmaceuticals, LLC. · not yet recruiting · Endometrial Neoplasms, Soft Tissue Sarcoma (STS), Breast Neoplasms · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in glioblastoma, ranked by citations from NIH iCite, fetched 2026-11-12 11:22 UTC. The ranking covers the 200 most relevant of 9 PubMed records, and a shared surname and initials can bring in a namesake. All 9 on PubMed
- Gain of function of mutant TP53 in glioblastoma: prognosis and response to temozolomide.Ann Surg Oncol · 201483 citationsRCR 2.4
- Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma.Oncotarget · 201671 citationsRCR 2.4
- 52 citationsRCR 1.4
- Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade.Neurosurgery · 201931 citationsRCR 1.1
- Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center, Randomized, Parallel, Open-label, Phase II Clinical Trial.Chin Med J (Engl) · 201516 citationsRCR 0.6
- Intrathecal CRISPR-edited allogeneic IL-13Rα2 CAR T Cells for recurrent high-grade Glioma: preclinical characterization and phase I trial.Nat Commun · 20269 citationsRCR 4.5
- Modulation of O6-methylguanine-DNA methyltransferase-mediated nimustine resistance in recurrent malignant gliomas by streptozotocin--a preliminary report.Anticancer Res · 19957 citationsRCR 0.2
- Single-Dose Pharmacokinetics, Safety, and Tolerability of Avadomide (CC-122) in Subjects With Mild, Moderate, or Severe Renal Impairment.Clin Pharmacol Drug Dev · 20206 citationsRCR 0.3